Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

171.30
Delayed Data
As of May 04
 -1.20 / -0.70%
Today’s Change
147.81
Today|||52-Week Range
203.30
-7.42%
Year-to-Date

Today’s Trading

Previous close172.50
Today’s open172.66
Day’s range170.65 - 174.82
Volume1,211,739
Average volume (3 months)1,248,174
Market cap$34.4B
Dividend yield--
Data as of 4:00pm ET, 05/04/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+11.87%
Earnings growth (next 5 years)+21.56%
Revenue growth (last year)+46.49%
P/E ratio58.7
Price/Sales16.55
Price/Book10.40

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.84-1.14%
VRTXVertex Pharmaceutica...+0.70+0.56%
PRGOPerrigo Company PLC+1.68+0.90%
ZTSZoetis Inc+0.79+1.77%
Data as of 4:04pm ET, 05/04/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.40
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers